Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma
NCT ID: NCT01584726
Last Updated: 2014-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
400 participants
INTERVENTIONAL
2012-12-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation
NCT01515995
Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation
NCT02584738
Magnesium Nebulization Utilization in Management of Pediatric Asthma
NCT01429415
Double Dose Magnesium Sulphate in Moderate-severe Asthma in Paediatrics
NCT04465175
Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.
NCT02455687
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
follow asthma severity score and length of stay
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
magnesium sulfate arm
magnesium sulfate with standard therapy
Magnesium Sulfate
single dose of magnesium sulfate nebulization
placebo arm
placebo with standard therapy
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magnesium Sulfate
single dose of magnesium sulfate nebulization
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* History of neuromuscular disease, cardiac disease, renal disease, or underlying chronic lung disease
* Use of oral steroid medication within 72 hours of presentation
* Radiographic evidence of pneumonia at presentation
* Administration of intravenous magnesium sulfate prior to study enrollment
2 Years
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hamad Medical Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
KHALID AL ANSARI, MD
Role: PRINCIPAL_INVESTIGATOR
SENIOR CONSULTANT-HEAD OF PEDIATRIC EMERGENCY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hamad Medical Corporation
Doha, Qatar, Qatar
Pediatric Emergency Centre
Doha, , Qatar
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Alansari K, Ahmed W, Davidson BL, Alamri M, Zakaria I, Alrifaai M. Nebulized magnesium for moderate and severe pediatric asthma: A randomized trial. Pediatr Pulmonol. 2015 Dec;50(12):1191-9. doi: 10.1002/ppul.23158. Epub 2015 Feb 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
#12095/12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.